- Home
- RAPP vs CINT Comparison
RAPP vs CINT Comparison
Compare RAPP & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPP
- CINT
- Stock Information
- Founded
- RAPP 2022
- CINT 1995
- Country
- RAPP United States
- CINT Brazil
- Employees
- RAPP N/A
- CINT N/A
- Industry
- RAPP
- CINT EDP Services
- Sector
- RAPP
- CINT Technology
- Exchange
- RAPP Nasdaq
- CINT Nasdaq
- Market Cap
- RAPP 844.6M
- CINT 823.0M
- IPO Year
- RAPP 2024
- CINT 2021
- Fundamental
- Price
- RAPP $18.46
- CINT $6.13
- Analyst Decision
- RAPP Strong Buy
- CINT Buy
- Analyst Count
- RAPP 4
- CINT 7
- Target Price
- RAPP $37.33
- CINT $7.40
- AVG Volume (30 Days)
- RAPP 136.9K
- CINT 64.6K
- Earning Date
- RAPP 02-10-2025
- CINT 11-14-2024
- Dividend Yield
- RAPP N/A
- CINT N/A
- EPS Growth
- RAPP N/A
- CINT 15.05
- EPS
- RAPP N/A
- CINT 0.16
- Revenue
- RAPP N/A
- CINT $410,247,558.00
- Revenue This Year
- RAPP N/A
- CINT $8.67
- Revenue Next Year
- RAPP N/A
- CINT $14.87
- P/E Ratio
- RAPP N/A
- CINT $37.58
- Revenue Growth
- RAPP N/A
- CINT N/A
- 52 Week Low
- RAPP $16.55
- CINT $3.34
- 52 Week High
- RAPP $29.74
- CINT $8.04
- Technical
- Relative Strength Index (RSI)
- RAPP N/A
- CINT 40.37
- Support Level
- RAPP N/A
- CINT $5.74
- Resistance Level
- RAPP N/A
- CINT $6.31
- Average True Range (ATR)
- RAPP 0.00
- CINT 0.26
- MACD
- RAPP 0.00
- CINT -0.04
- Stochastic Oscillator
- RAPP 0.00
- CINT 26.71
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.